P&K Skin Research Center Co., Ltd.

KOSDAQ:A347740 Stock Report

Market Cap: ₩63.1b

P&K Skin Research Center Past Earnings Performance

Past criteria checks 2/6

P&K Skin Research Center has been growing earnings at an average annual rate of 27.1%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 12.1% per year. P&K Skin Research Center's return on equity is 8.8%, and it has net margins of 38.3%.

Key information

27.1%

Earnings growth rate

30.0%

EPS growth rate

Life Sciences Industry Growth53.7%
Revenue growth rate12.1%
Return on equity8.8%
Net Margin38.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

We Think That There Are More Issues For P&K Skin Research Center (KOSDAQ:347740) Than Just Sluggish Earnings

Mar 28
We Think That There Are More Issues For P&K Skin Research Center (KOSDAQ:347740) Than Just Sluggish Earnings

Revenue & Expenses Breakdown

How P&K Skin Research Center makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A347740 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2417,6716,7633,8291,512
30 Jun 2416,2835,3563,9331,457
31 Mar 2415,5004,6974,0661,400
31 Dec 2314,8434,8133,9981,357
30 Sep 2315,7665,3233,9721,508
30 Jun 2316,6026,0803,8051,636
31 Mar 2317,7407,1703,5901,675
31 Dec 2217,9577,1303,4761,670

Quality Earnings: A347740 has high quality earnings.

Growing Profit Margin: A347740's current net profit margins (38.3%) are higher than last year (33.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if A347740's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare A347740's past year earnings growth to its 5-year average.

Earnings vs Industry: A347740 earnings growth over the past year (27.1%) did not outperform the Life Sciences industry 39.6%.


Return on Equity

High ROE: A347740's Return on Equity (8.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 03:04
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

P&K Skin Research Center Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sae-rom LeeDaishin Securities Co. Ltd.
Jongsun ParkEugene Investment & Securities Co Ltd.
Jae-il ParkKiwoom Securities Co., Ltd.